Phase II evaluation of bisantrene in refractory multiple myeloma
- 1 November 1991
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 9 (4), 329-331
- https://doi.org/10.1007/bf00183574
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.Journal of Clinical Oncology, 1986
- Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival durationBlood, 1983
- Direct cloning of human malignant melanoma in soft agar cultureCancer, 1982